Price
$2.31
Increased by +1.32%
Dollar Volume (20D)
1.12 M
ADR%
3.45
Earnings Report Date (estimate)
Apr 24, 24
Shares Float
88.53 M
Shares Outstanding
99.17 M
Shares Short
5.27 M
Market Cap.
226.1 M
Beta
1.47
Price / Earnings
N/A
20D Range
2.22 2.64
50D Range
2.22 2.95
200D Range
2.22 4.3
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Jan 31, 24 -0.1
Decreased by -400%
-0.05
Decreased by -100%
Nov 7, 23 -0.03
Increased by +50%
-0.05
Increased by +40%
Aug 9, 23 -0.03
Increased by +25%
0.01
Decreased by -400%
Apr 26, 23 0.01
Increased by +200%
-0.01
Increased by +200%
Feb 1, 23 -0.02
Decreased by -1.15 K%
-0.03
Increased by +33.33%
Nov 2, 22 -0.06
Decreased by -500%
-0.02
Decreased by -200%
Aug 10, 22 -0.04
Decreased by -300%
-0.06
Increased by +33.33%
Apr 27, 22 -0.01
Decreased by -138.1%
-0.04
Increased by +75%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 107.24 M
Decreased by -6.55%
-9.62 M
Decreased by -413.39%
Decreased by -8.97%
Decreased by -449.4%
Sep 30, 23 103.89 M
Increased by +7.67%
-2.97 M
Increased by +45.51%
Decreased by -2.86%
Increased by +49.39%
Jun 30, 23 118.29 M
Increased by +7.52%
-2.56 M
Increased by +25.96%
Decreased by -2.16%
Increased by +31.13%
Mar 31, 23 118.06 M
Increased by +22.76%
599 K
Increased by +157.27%
Increased by +0.51%
Increased by +146.65%
Dec 31, 22 114.76 M
Decreased by -1.3%
-1.87 M
Decreased by -1.15 K%
Decreased by -1.63%
Decreased by -1.16 K%
Sep 30, 22 96.49 M
Decreased by -10.19%
-5.45 M
Decreased by -430.06%
Decreased by -5.65%
Decreased by -490.2%
Jun 30, 22 110.02 M
Decreased by -0.82%
-3.45 M
Increased by +68.88%
Decreased by -3.14%
Increased by +68.62%
Mar 31, 22 96.17 M
Decreased by -6.23%
-1.05 M
Decreased by -168.21%
Decreased by -1.09%
Decreased by -186.03%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.